A Phase 1, Open-Label, Crossover Study to Assess the Potential for Gastric pH-Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants
Latest Information Update: 24 Jul 2024
At a glance
- Drugs DNL-151 (Primary) ; Rabeprazole
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Biogen
Most Recent Events
- 14 Jun 2024 Status changed from active, no longer recruiting to completed.
- 10 May 2024 Planned End Date changed from 7 May 2024 to 10 Jun 2024.
- 10 May 2024 Planned primary completion date changed from 7 May 2024 to 10 Jun 2024.